InsidersTradesSigma
Total declarations
Company
▲ Purchases (6 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
6
Disclosed sells
0
T+90 hit rate
22%
T+90 mean return
-29.5%
Across 9 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by De Rubertis Francesco, Director. Officer active across 1 company, notably Centessa Pharmaceuticals plc. In total, 15 disclosures have been recorded. Split: 6 buys · 0 sell. Total volume traded: €1.7m. Activity tracked since 26 November 2021. The latest transaction was filed on 21 March 2022 (J). Regulator: SEC (Form 4). The full history is openly available.
Declarations15 total
4,398,519 sharesOrdinary SharesSEC:0001470831-26-000615:0
55,677 sharesOrdinary SharesSEC:0001470831-26-000615:1
3,936,970 sharesOrdinary SharesSEC:0001470831-26-000615:2
93,526 sharesOrdinary SharesSEC:0001470831-26-000615:3
11,197,303 sharesOrdinary SharesSEC:0001470831-26-000615:4
281,162 sharesOrdinary SharesSEC:0001470831-26-000615:5
1,794,211 shares0Ordinary SharesSEC:0000899243-22-011941:0
33,530 shares@ US$12.820.0062% mcap21.9% of flowOrdinary SharesSEC:0000899243-21-046972:0
Ideal exit: 29 Aug 2022 (T+270)
33,530 shares@ US$12.8221.9% of flowOrdinary SharesSEC:0000899243-21-046972
Ideal exit: 29 Aug 2022 (T+270)
35,992 shares@ US$11.6221.4% of flowOrdinary SharesSEC:0000899243-21-046599
Ideal exit: 27 Aug 2022 (T+270)
35,992 shares@ US$11.620.0060% mcap21.4% of flowOrdinary SharesSEC:0000899243-21-046599:0
Ideal exit: 27 Aug 2022 (T+270)
11,543 shares@ US$11.33530.0019% mcap6.7% of flowOrdinary SharesSEC:0000899243-21-046320:0
Ideal exit: 23 Aug 2022 (T+270)
11,543 shares@ US$11.33536.7% of flowOrdinary SharesSEC:0000899243-21-046320
Ideal exit: 23 Aug 2022 (T+270)
1,886,990 sharesOrdinary SharesSEC:0000899243-21-022071:0
1,886,990 sharesOrdinary SharesSEC:0000899243-21-022071
15 of 15 declarations
About De Rubertis Francesco
Francesco De Rubertis is a Board Member at Centessa Pharmaceuticals plc. He plays a key role in the governance of the company, contributing to strategic decision-making and overseeing activities.
